Abstract
The amino acid L-glutamate is generally recognized as the major excitatory neurotransmitter of the mammalian central nervous system (CNS) and glutamate receptors play a major role in fast excitatory synaptic transmission. Nmethyl- D-aspartate (NMDA)-type glutamate receptors are widely distributed throughout the CNS and operate ligandactivated ion channels. The activation and function of NMDA receptors are modulated by a variety of endogenous and exogenous compounds. Various anesthetic protocols have been used in pediatric medicine for many years in the absence of clear systematic assessment concerning drug exposure and possible adverse effects. It is known that most of the currently used anesthetic drugs have either NMDA receptor blocking or gamma-amino butyric acid (GABA) receptor activating properties. It has been reported that anesthetics such as ketamine, an NMDA receptor antagonist, cause neuronal cell death in rodents when administered during critical periods of development. The window of vulnerability to the neuronal effects of pediatric anesthetics seems to be restricted to the period of rapid synaptogenesis, also known as the brain growth-spurt period. Accentuated neurodegenerative mechanisms in the immature brain can thus increase neuronal susceptibility to exposure to anesthetic agents. Anesthetics that block NMDA or activate GABA receptors consistently increase cell death in the neonatal brain, suggesting that the physiological stimulation of NMDA receptors is necessary for normal neuronal synaptogenesis, differentiation, and survival during development. The main purposes of this review are to outline progress in the application of pharmacogenomic/systems approaches and animal models to systematically evaluate dose-response and time-course effects of anesthetic agents; to describe what is known about underlying mechanisms; and to define the relationship between altered NMDA receptor expression and the potential of anesthetics to cause toxicity during development. It should be mentioned that much of this discussion is based on experiments conducted only with ketamine. This is due in part to the use of ketamine in critical early studies and the volume of preclinical experimental work performed with this agent, and because comparative (rodent and nonhuman primates) data exist for this compound. The findings of the ketamine studies to date are sufficiently strong enough to cause concern for other agents which affect the same receptors.
Keywords: Glutamate neurotransmission, anesthetic agent, neurodegeneration
Central Nervous System Agents in Medicinal Chemistry
Title: Ketamine and Glutamate Receptors: Potential Toxicity of General Anesthetics during Rapid Brain Development
Volume: 8 Issue: 2
Author(s): Cheng Wang, Xuan Zhang, Xiaoju Zou, Merle G. Paule and William Slikker Jr.
Affiliation:
Keywords: Glutamate neurotransmission, anesthetic agent, neurodegeneration
Abstract: The amino acid L-glutamate is generally recognized as the major excitatory neurotransmitter of the mammalian central nervous system (CNS) and glutamate receptors play a major role in fast excitatory synaptic transmission. Nmethyl- D-aspartate (NMDA)-type glutamate receptors are widely distributed throughout the CNS and operate ligandactivated ion channels. The activation and function of NMDA receptors are modulated by a variety of endogenous and exogenous compounds. Various anesthetic protocols have been used in pediatric medicine for many years in the absence of clear systematic assessment concerning drug exposure and possible adverse effects. It is known that most of the currently used anesthetic drugs have either NMDA receptor blocking or gamma-amino butyric acid (GABA) receptor activating properties. It has been reported that anesthetics such as ketamine, an NMDA receptor antagonist, cause neuronal cell death in rodents when administered during critical periods of development. The window of vulnerability to the neuronal effects of pediatric anesthetics seems to be restricted to the period of rapid synaptogenesis, also known as the brain growth-spurt period. Accentuated neurodegenerative mechanisms in the immature brain can thus increase neuronal susceptibility to exposure to anesthetic agents. Anesthetics that block NMDA or activate GABA receptors consistently increase cell death in the neonatal brain, suggesting that the physiological stimulation of NMDA receptors is necessary for normal neuronal synaptogenesis, differentiation, and survival during development. The main purposes of this review are to outline progress in the application of pharmacogenomic/systems approaches and animal models to systematically evaluate dose-response and time-course effects of anesthetic agents; to describe what is known about underlying mechanisms; and to define the relationship between altered NMDA receptor expression and the potential of anesthetics to cause toxicity during development. It should be mentioned that much of this discussion is based on experiments conducted only with ketamine. This is due in part to the use of ketamine in critical early studies and the volume of preclinical experimental work performed with this agent, and because comparative (rodent and nonhuman primates) data exist for this compound. The findings of the ketamine studies to date are sufficiently strong enough to cause concern for other agents which affect the same receptors.
Export Options
About this article
Cite this article as:
Wang Cheng, Zhang Xuan, Zou Xiaoju, Paule G. Merle and Jr. Slikker William, Ketamine and Glutamate Receptors: Potential Toxicity of General Anesthetics during Rapid Brain Development, Central Nervous System Agents in Medicinal Chemistry 2008; 8 (2) . https://dx.doi.org/10.2174/187152408784533914
DOI https://dx.doi.org/10.2174/187152408784533914 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Efficient Purification of rhG-CSF and its PEGylated Forms and Evaluation for In Vitro Activities
Protein & Peptide Letters Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases
Current Immunology Reviews (Discontinued) Oxidative Stress and Lipid Peroxidation in Prolonged Users of Methamphetamine
Drug Metabolism Letters Meet Our Editorial Board Member:
Current Vascular Pharmacology Synthesis and Biological Evaluation of Curcumin-Nitroxide-Based Molecular Hybrids as Antioxidant and Anti-Proliferative Agents
Medicinal Chemistry The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum
Current Neuropharmacology Editorial: Spatial Cognition in Normal Aging, MCI and AD
Current Alzheimer Research Exploiting Anti-Inflammation Effects of Flavonoids in Chronic Inflammatory Diseases
Current Pharmaceutical Design Fast Disintegrating Film Approach for the Oral Delivery of Zolmitriptan: Formulation, <i>In Vitro</i> and <i>In Vivo</i> Evaluation
Drug Delivery Letters Formulation Development and Evaluation of Novel Vesicular Carrier for Enhancement of Bioavailability of Poorly Soluble Drug
Pharmaceutical Nanotechnology Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Current Neuropharmacology Patent Annotations
Recent Patents on Inflammation & Allergy Drug Discovery Advances in Clinical Study of Curcumin
Current Pharmaceutical Design Functions of S100 Proteins
Current Molecular Medicine IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma
Current Medicinal Chemistry Application of ERP in Neurolinguistics: A Review of Recent Studies
Neuroscience and Biomedical Engineering (Discontinued) Chaperones and Cardiac Misfolding Protein Diseases
Current Protein & Peptide Science Microwave Induced One Pot Ugi Multicomponent Reaction of Fluoroquino Lone Scaffolds: Their Biological Evaluation
Current Green Chemistry Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom
Current Respiratory Medicine Reviews Interactions of Sex Steroids with Mechanisms of Inflammation
Current Drug Targets - Inflammation & Allergy